FIGURE 2.

Therapeutic strategies that target CAFs for CRC treatment. A variety of inhibitors, agonists, or neutralizing antibodies targeting different signaling pathways or molecules that contribute to CAFs’ versatile roles are proposed to interfere some key processes during CRC pathogenesis for clinical treatment.